Company / Depreciation & Amortization
PLUS THERAPEUTICS, INC. Depreciation & Amortization History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$872.0K
FY2025
5-year range
$628.0K / $2.2M
FY2021-FY2025
Trend
+38.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $628,000 in FY2024 to $2M in FY2018.
Based on SEC 10-K filings.
$872,000 in FY2025 with a 10-year CAGR of -6.1%.
Improved from $2M to $872,000 over the past 7 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -6.1%
Key checks
Key Insights
- In FY2025, depreciation & amortization increased 38.9% year-over-year.
- Peak depreciation & amortization was recorded in FY2018.
- Lowest depreciation & amortization in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $872.0K | +38.9% |
| FY2024 | $628.0K | -70.8% |
| FY2018 | $2.2M | +82.0% |
| FY2017 | $1.2M | +8.1% |
| FY2016 | $1.1M | -32.9% |
| FY2015 | $1.6M | +74.7% |
| FY2014 | $933.0K | +9.1% |
| FY2013 | $855.0K | -8.2% |
| FY2012 | $931.0K | -44.6% |
| FY2011 | $1.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026